Act | West FY 22 Semi-Annual Report: April 2022 - September 2022

This report outlines the key achievements and challenges in the last six months of the fourth year of program implementation, spanning the period April 1, 2022 - September 31, 2022.

Act West FY 2022-SAR II-Apr-Sept 2022_0.pdf


Collage of images from the Act | West program on the cover page of the SAR II
Semi-annual report
Year of publication
All Preventive Chemotherapy NTDs
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
AIM Initiative, Deloitte, FHI360, HDI, Helen Keller International, World Vision